Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Vitamin D Status and SARS-CoV-2 Positivity in Lebanon Among Adults: A Cross-Sectional Study in South Lebanon

Madar et al., COVID, doi:10.3390/covid5070097, Jun 2025
https://c19early.org/madar.html
Case 34% Improvement Relative Risk Vitamin D for COVID-19  Madar et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 257 patients in Lebanon (November 2021 - April 2022) Fewer cases with higher vitamin D levels (not stat. sig., p=0.15) c19early.org Madar et al., COVID, June 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
5,900+ studies for 172 treatments. c19early.org
Cross-sectional study of 384 adults showing no significant association between vitamin D levels and test positivity.
This is the 222nd COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 742,551,930,931 vigintillion).
risk of case, 33.8% lower, OR 0.66, p = 0.15, high D levels (≥50 ng/mL) 143, low D levels (<30 ng/mL) 114, adjusted per study, inverted to make OR<1 favor high D levels (≥50 ng/mL), RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Madar et al., 27 Jun 2025, retrospective, Lebanon, peer-reviewed, mean age 38.8, 4 authors, study period 23 November, 2021 - 30 April, 2022. Contact: a.a.madar@medisin.uio.no.
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit